Spanish | Català | English Labco.eu | Home Page | High Value Tests | Contacts: Results Business Laboratories New diagnostic technologies allow adapting the right patient to the right treatment at the right time Labco European Leader Spain and Portugal Expanding Company Labco in Numbers Contacts: Home Page > News What's new? to share: BRCA PLUS Hereditary gynecological cancer prevention Hereditary gynecological cancer is characterized by its incidence at an early age, even before the age of 40, and accounts for between 5-15% of gynecological cancer cases in women. The origin of this genetic susceptibility frequently resides in mutations in the BRCA1 and BRCA2 genes, although there are other genes related to breast, ovarian and endometrial cancer that should be studied to provide more complete information to the professional. What's new? See all News A200 Fatty acids ADGen AginGen Sleep disturbances Array CGH BrainScreen BRCA BRCA PLUS CardioGen CardioScore Cardiovascular COLONPLUS DAOPlus DermaScreen Detox Test Intestinal dysbiosis Oxidative stress Pharmacogenetics-PGx Basic Pharmacogenetics-PGx Cardio Pharmacogenetics-PGx Neuro Pharmacogenetics-PGx Onco Glaucoma PEX Test Gluten Detect Guardant360 HPV OncoTect® Genetic Footprint Omega-3 Index ImmunoAging ISAC® Telomeric Length M-ES Test Macula Test Balm Microdent MigraTest Mineral Hair Test neoBona NutriGen NutriHealth NutriScreen ObesGen OsteoGen Paternity PCA3 Dry Eye Profile Intestinal Permeability preconGEN Prosigna Recombine Septina9 Fetal sex in maternal blood SportGen SportPlus Autologous Ophthalmological Serum TDAGEN + The Liquid Biopsy ThromboInCode Lymphocyte typing News See all the news Half of the people with Glaucoma are unaware of it. 03/13/2017 Read more 5 tips to take care of your heart this Christmas 12/21/2016 Read more Tips to prevent the flu 11/04/2016 Read more Contacts | Site Map | Privacy Policy | Recommend Site | Add to favorites Back to the start Copyright © 2011-2017 Labco. All rights reserved Follow us on: